Director Moukheibir sells entire 23.5K MLTX holding for $1.1M at $48.79; post-sale zero position
Catherine Moukheibir, a director at MoonLake Immunotherapeutics, sold 23,500 shares on 2025-07-03 at $48.79 per share, completely liquidating her holdings and leaving zero shares post-transaction. The sale occurred when MLTX was trading below its 52-week high of $56.30 (current price $47.50 is -15.6% from that high), though the stock has appreciated +44.7% over the past 90 days. The full liquidation of a director's entire position is a notable signal, particularly given that the company reported negative net income of $-39,944,000.00 over its most recent full fiscal year. An investor should monitor whether this complete exit by a board member reflects changed assessments of company fundamentals or future prospects.